Pendyala L. Schwartz G. Smith P. Zdanowicz J. Murphy M. Hausheer F Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy. Cancer Chemotherapy & Pharmacology. 51(5):376-84, 2003 May (view details on MedLine)
Schwartz GN, Pendyala L, Kindler H, Meropol N, Perez R, Raghavan D, and Creaven P The clinical development of paclitaxel and the paclitaxel/carboplatin combination. Eur J Cancer 34(10):1543-1548, 1998 (view details on MedLine)
Schwartz GN, Teicher BA, Eder JP, Korbut T, Holden SA, Ara G, Herman TS Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine. Cancer Chemotherapy and Pharmacology, 1993, 32:455-62 (view details on MedLine)
Professional Interests:
Cancer chemotherapy and endocrine therapy for breast cancer, signal transduction pathways in breast cancer, and new drug development.
Courses Taught:
None
Grant Information:
ZD1839 (Iressa) in Tamoxifen-Resistant Metastatic Breast Cancer, Principal Investigator, (NCI-NIH)
S14 as a Therapeutic Targetin Breast Cancer, Co-investigator, (DOD)